<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Reproduction and Endocrinology</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C207B679-3105-4B7B-9092-60276D81E2E2"><gtr:id>C207B679-3105-4B7B-9092-60276D81E2E2</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:surname>Greenwood</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B4AA07B4-DC50-40EF-B1A4-2A2EA7E9B33D"><gtr:id>B4AA07B4-DC50-40EF-B1A4-2A2EA7E9B33D</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Johnson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4BF81D8E-FBB0-4914-AA61-15E53E2831BB"><gtr:id>4BF81D8E-FBB0-4914-AA61-15E53E2831BB</gtr:id><gtr:firstName>Rachel</gtr:firstName><gtr:otherNames>Marie</gtr:otherNames><gtr:surname>Tribe</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3D1A9358-CF63-4B22-9E88-DEA46FDF7E1A"><gtr:id>3D1A9358-CF63-4B22-9E88-DEA46FDF7E1A</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/719E54FF-DCA9-46E6-8A8A-7C91077CBD3A"><gtr:id>719E54FF-DCA9-46E6-8A8A-7C91077CBD3A</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:otherNames>Irving</gtr:otherNames><gtr:surname>Aaronson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1100243"><gtr:id>315881F4-D836-47CB-9CC6-84710929E386</gtr:id><gtr:title>Kv7 channel activators -a novel treatment for preterm labour?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100243</gtr:grantReference><gtr:abstractText>Every year, over 40,000 babies are born too early. Whilst some of these babies will be healthy, many will die shortly after birth and those who survive risk developing lifelong disability or behavioural problems. Ideally, obstetricians would like to be able to predict which women are at risk of delivering their baby prematurely and prevent them going into labour too early. However, this is not yet possible and women present at hospital in preterm labour requiring drugs to stop their uterus (womb) from contracting. The drugs currently available are not very effective and there is a real need to develop better treatments. Our research has identified a new class of drugs (Kv7 channel activators) that can potentially stop the uterus from contracting. Before we can begin testing these drugs in pregnant women, we need to show that they are safe to use in pregnancy. Our project aims to do this and also to develop our understanding of how these drugs can target the uterus specifically.</gtr:abstractText><gtr:technicalSummary>Premature births (37/40 weeks of gestation) account for ~7% of the deliveries in the UK, yet 75% of neonatal deaths, and most admissions to intensive care occur in infants born before 32 weeks of gestation The cost of premature birth in the UK was recently estimated at #939 million/year and economic modelling suggests that delaying preterm birth by one week could save #260 million/year. The ultimate strategy for reducing the impact of preterm labour would be the development of a prediction tool with high sensitivity and specificity to enable early pregnancy stratification of women according to risk, and development of prophylactic therapy. However, in the absence of either, the development of effective tocolytics (drugs that inhibit uterine contractions) would be a major advance in management and prevention of preterm delivery. This application focuses on the unmet need to develop a safe and effective tocolytic therapy that can prolong gestation (when appropriate) for more than one or two days and improve neonatal outcomes for babies. The overarching goal of this project is to facilitate the translation of our recent novel animal and human in vitro data on Kv7 channels into a useful therapeutic tool for the treatment of preterm labour in women. Firstly, our aim is to provide ?proof of principle? data demonstrating that Kv7 activators can inhibit uterine contractions in vivo in pregnant mice (including preterm labour models) and that they are associated with limited side effects; an essential step in the translation pathway. Secondly, to enhance the potential for use of Kv7 channels modulators in pregnant women, the predominant Kv7 channel in myometrium from labouring women needs to be identified. Radio-telemetry will be utilised to measure uterine pressure and cardiovascular parameters and micro-ultrasound to assess uterine artery blood flow in vivo. Kv7 channel subunit composition and function will be explored, using combined electrophysiological/molecular approaches, in human myometrium from pregnant women (?labour). Together this programme of work will aid selection and development of specific Kv7 channel activators for translation to clinical studies.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-01</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>748684</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Uterine Telemetry Collaboration</gtr:description><gtr:id>1AC327FB-76BB-4DB6-B193-8D75B7CBAF52</gtr:id><gtr:impact>Technique has been implemented and data will be included in future publications 
More members of my team have been trained in the technique, including an MRC funded PhD student. He is now training others including colleagues from other UK institutions. We have achieved our aim which was to become an known UK hub for this technique. This has saved money as we have not needed to send others to the US to learn the technique.</gtr:impact><gtr:partnerContribution>Provided a week long training session and continued advice for implementation of the technique in our laboratory.</gtr:partnerContribution><gtr:piContribution>Training to undertake work planned on the grant. Training took place at the Washington University, St Louis USA.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>45F0BB9F-F579-4EE1-9EE5-93521139EE85</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Physiological Society</gtr:fundingOrg><gtr:id>D60C2ED4-B6E2-4C14-88E8-A091E3C7E6E0</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Award</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Physiological Society</gtr:fundingOrg><gtr:id>F9030D76-387B-4F1B-B56D-A4683A98011B</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Award</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Physiological Society</gtr:fundingOrg><gtr:id>2077F303-CC37-4448-8C0A-480336F46E8A</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Video capture of animals giving birth in cages</gtr:description><gtr:id>127922E6-3F6B-43E4-AE15-4ECDC7993EA3</gtr:id><gtr:impact>Reduction in use of uterine telemetry (surgical technique)</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Video recording of timing of birth</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9175362E-84CC-4807-8B9F-E3AA92A9AE2F"><gtr:id>9175362E-84CC-4807-8B9F-E3AA92A9AE2F</gtr:id><gtr:title>Molecular and functional characterisation of KCNQ- and KCNE-encoded KV7 potassium channels in human term pregnant myometrium</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/620249f8ede8dc4c9244c7cdc907b296"><gtr:id>620249f8ede8dc4c9244c7cdc907b296</gtr:id><gtr:otherNames>Mansour Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31C9AD87-7314-4F1A-8E87-B828AF818E3E"><gtr:id>31C9AD87-7314-4F1A-8E87-B828AF818E3E</gtr:id><gtr:title>Computational modeling reveals key contributions of KCNQ and hERG currents to the malleability of uterine action potentials underpinning labor.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d327376cbbb9f172d14bf2d9db4f4e95"><gtr:id>d327376cbbb9f172d14bf2d9db4f4e95</gtr:id><gtr:otherNames>Tong WC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/717BB355-6988-4451-A898-CF5598774585"><gtr:id>717BB355-6988-4451-A898-CF5598774585</gtr:id><gtr:title>Molecular and functional characterisation of KV7 channels in mammalian myometrium during pregnancy and parturition</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9e3ff0a8c1269cf0c599471a2ca08fa1"><gtr:id>9e3ff0a8c1269cf0c599471a2ca08fa1</gtr:id><gtr:otherNames>Mansour Yosef Tariq</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FACCF75-8402-43F8-81D5-79784CA48590"><gtr:id>7FACCF75-8402-43F8-81D5-79784CA48590</gtr:id><gtr:title>Kv7 channel activators inhibit uterine contractility and delay preterm birth in mice</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da9bf48d99b3bbbcd40a75527bff0cb9"><gtr:id>da9bf48d99b3bbbcd40a75527bff0cb9</gtr:id><gtr:otherNames>Mansour YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48AF481C-BA8B-4716-A1F1-B50C639311F2"><gtr:id>48AF481C-BA8B-4716-A1F1-B50C639311F2</gtr:id><gtr:title>Impact of Kv7 and Kv11 voltage-gated potassium channel modulators on contractile activity of myometrium from pregnant women at term</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da9bf48d99b3bbbcd40a75527bff0cb9"><gtr:id>da9bf48d99b3bbbcd40a75527bff0cb9</gtr:id><gtr:otherNames>Mansour YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15098982-3E91-4C3B-95D3-46B5C98DCA17"><gtr:id>15098982-3E91-4C3B-95D3-46B5C98DCA17</gtr:id><gtr:title>Expression of voltage-dependent potassium channels in first trimester human placentae.</gtr:title><gtr:parentPublicationTitle>Placenta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f76a5fba1cf34263b69d6e0d3ba8dcee"><gtr:id>f76a5fba1cf34263b69d6e0d3ba8dcee</gtr:id><gtr:otherNames>Mistry HD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0143-4004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FD83D01-2555-445B-880E-5F4AF58591E6"><gtr:id>7FD83D01-2555-445B-880E-5F4AF58591E6</gtr:id><gtr:title>KV7 channel activity in pregnant human myometrial smooth muscle cells</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2c18b3dd832d78b186e02cc952015cc"><gtr:id>c2c18b3dd832d78b186e02cc952015cc</gtr:id><gtr:otherNames>Mahn K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20EE5EFF-3D59-4B62-9DAA-1E9246FA5A08"><gtr:id>20EE5EFF-3D59-4B62-9DAA-1E9246FA5A08</gtr:id><gtr:title>KV7 activators inhibit uterine contractility and delay preterm birth in mice</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da9bf48d99b3bbbcd40a75527bff0cb9"><gtr:id>da9bf48d99b3bbbcd40a75527bff0cb9</gtr:id><gtr:otherNames>Mansour YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2EF28CAD-8B53-4686-BB66-8A6A2CB715A0"><gtr:id>2EF28CAD-8B53-4686-BB66-8A6A2CB715A0</gtr:id><gtr:title>Human Myometrium KV7 Channel a and ? Subunit Expression Profiles at Term and during Labour.</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da9bf48d99b3bbbcd40a75527bff0cb9"><gtr:id>da9bf48d99b3bbbcd40a75527bff0cb9</gtr:id><gtr:otherNames>Mansour YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F03B051-D40C-437D-81A1-6A685069D95B"><gtr:id>0F03B051-D40C-437D-81A1-6A685069D95B</gtr:id><gtr:title>Impact of Kv7 voltage-gated potassium channel modulators on contractile activity of myometrium from pregnant women at term</gtr:title><gtr:parentPublicationTitle>Proceedings of The Physiological Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/620249f8ede8dc4c9244c7cdc907b296"><gtr:id>620249f8ede8dc4c9244c7cdc907b296</gtr:id><gtr:otherNames>Mansour Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1730AF29-6BF5-4EAC-ABE0-CECA34E21E5D"><gtr:id>1730AF29-6BF5-4EAC-ABE0-CECA34E21E5D</gtr:id><gtr:title>Kv7 and Kv11 channels in myometrial regulation.</gtr:title><gtr:parentPublicationTitle>Experimental physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/678e522d142fd3291bb26abc11145736"><gtr:id>678e522d142fd3291bb26abc11145736</gtr:id><gtr:otherNames>Greenwood IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0958-0670</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100243</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>